<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02717143</url>
  </required_header>
  <id_info>
    <org_study_id>15677</org_study_id>
    <nct_id>NCT02717143</nct_id>
  </id_info>
  <brief_title>French National Observatory Tracking Viral Myocarditis: Mortality, Cardiovascular Events, Sequels on (Magnetic Resonance Imaging) MRI</brief_title>
  <acronym>MYOCARDITIRM</acronym>
  <official_title>French National Observatory Tracking Viral Myocarditis: Mortality, Cardiovascular Events, Sequels on (Magnetic Resonance Imaging) MRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Cardiology Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>French Cardiology Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute myocarditis is a serious illness affecting a young population with a very variable
      course (of full recovery at the onset of dilated cardiomyopathy (DCM), or even sudden death).
      Very few studies have examined the predictors of death and serious cardiovascular events in
      acute myocarditis and have carried on numbers of restricted patients. What little data
      results in a lack of a precise recommendation on the management and the follow-up period of
      patients.

      This observational study should identify serious prognostic factor for cardiovascular events
      in order to provide a support strategy and more appropriate monitoring of myocarditis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients included in the study benefit from clinical monitoring, ultrasound and MRI as
      planned according to the habits of the center, regardless of the study. These clinical
      monitoring data, ultrasound and MRI will be collected as part of the study and if necessary
      telephone follow-up of cardiologists contractors will be made to complete the data. No
      additional examination will be conducted as part of this study. The data collected especially
      for cardiac MRI, will be based on the current monitoring protocol in each center.

      All patients included in this study have received information and signed a consent to the use
      of their data during hospitalization and follow-up.

      As part of this study, the inclusions are planned for a period of 2 years or more to reach a
      recruitment of 700 patients. The tracking target is 3 years, with an annual follow-up.

      Patient follow-up is made by the doctor who selected the patient. Clinical follow-up will be
      made at a consultation normally provided for in hospital or cardiology practice in this type
      of pathology.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality at 1 year of follow-up</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiovascular mortality at 1 year of follow-up</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause mortality at 3 years of follow-up</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of cardiovascular events at 3 years of follow-up</measure>
    <time_frame>3 years</time_frame>
    <description>Incidence of heart failure requiring hospitalization, diagnostic of DCM not posed before the episode of myocarditis, stroke, heart transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of sequelae of myocarditis in cardiac MRI for patients undergoing cardiac MRI in their monitoring at 3 years of follow-up</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Myocarditis</condition>
  <condition>Cardiomyopathy, Dilated</condition>
  <condition>Magnetic Resonance Imaging</condition>
  <arm_group>
    <arm_group_label>Acute myocarditis</arm_group_label>
    <description>Patients with a clinical picture suggestive of acute myocarditis: increase of troponin above the threshold defined by the pathological laboratory, associated with at least one of the three following criteria:
prolonged chest pain &gt; 10 minutes,
recent infectious context &lt;7 days
young subject and / or absence of cardiovascular risk factors and / or absence of significant coronary lesion
Patients will be included after completion of MRI confirm the diagnosis. They will be followed for 3 years, every year, by the doctor who included them in the study.
This is an observational study that does not affect the management of patients.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients with clinical features of acute myocarditis previously defined and
        who underwent cardiac MRI which concluded the diagnosis of acute myocarditis, having agreed
        to participate in the study and admitted in one of the participating centers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged 18 years and over

          -  Hospitalized suspect table of acute myocarditis: Eligible patients must have an
             increase of troponin I greater than the threshold value of the pathological laboratory
             of Biochemistry, associated with at least one of the three following criteria:

               1. prolonged chest pain&gt; 10 minutes,

               2. recent infectious context &lt;7 days

               3. subject young and / or absence of cardiovascular risk factors and / or absence of
                  significant coronary lesions in coronary angiography if the patient had a
                  coronary angiography.

          -  Having received a cardiac MRI which concluded the diagnosis of acute myocarditis
             according to the usual criteria of the center (Lake Louise criteria changed according
             to the habits of the center) There myocarditis when at least two of the following
             criteria are met: hyperintense T2; hyperintense Diffusion; myocardium ratio signal /
             peripheral muscle Gadolinium&gt; 4; contrast enhancement after injection of gadolinium
             chelate in cine-steady-state free precession (SSFP); nonischemic type of signal on
             delayed enhancement. These anomalies are segmental topography typically subepicardial.
             The analysis is made of the 17 segments of the left ventricle.

          -  Patient was informed and has given its consent for the study

        Exclusion Criteria:

          -  Refusal of consent

          -  Claustrophobia

          -  Formal contraindications to MRI (allergic reaction to gadolinium chelates, porters
             pregnancy or patients against-indicated materials listed on the site MRI Safety
             &quot;www.MRIsafety.com&quot;) :

               -  Incompatible heart Pacemaker and Defibrillator

               -  heart valve prostheses: valves Starr

               -  Metal splinters

               -  Coils intra cranial, intra cerebral surgical clips, bypass valves

               -  Neurological stimulators

               -  Insulin Pumps

               -  Orthopedic Materials: cervical fixation with cervical Halo vest or fixer

               -  Body piercing not be withdrawn
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Phalla OU, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claire BOULETI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Phalla OU, MD. PhD</last_name>
    <phone>33 1 40 25 86 90</phone>
    <email>phalla.ou@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claire BOULETI, MD, PhD</last_name>
    <phone>33 1 40 25 86 65</phone>
    <email>claire.bouleti@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bichat</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Bouleti</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006 Feb 14;113(6):876-90. Review.</citation>
    <PMID>16476862</PMID>
  </reference>
  <reference>
    <citation>Andréoletti L, Lévêque N, Boulagnon C, Brasselet C, Fornes P. Viral causes of human myocarditis. Arch Cardiovasc Dis. 2009 Jun-Jul;102(6-7):559-68. doi: 10.1016/j.acvd.2009.04.010. Epub 2009 Jul 31. Review.</citation>
    <PMID>19664576</PMID>
  </reference>
  <reference>
    <citation>Sinagra G, Maras P, D'Ambrosio A, Gregori D, Bussani R, Silvestri F, Morgera T, Pinamonti B, Salvi A, Alberti E, Di Lenarda A, Lardieri G, Klugmann S, Camerini F. [Clinical polymorphic presentation and natural history of active myocarditis: experience in 60 cases]. G Ital Cardiol. 1997 Aug;27(8):758-74. Italian.</citation>
    <PMID>9312504</PMID>
  </reference>
  <reference>
    <citation>McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000 Mar 9;342(10):690-5.</citation>
    <PMID>10706898</PMID>
  </reference>
  <reference>
    <citation>Eckart RE, Scoville SL, Campbell CL, Shry EA, Stajduhar KC, Potter RN, Pearse LA, Virmani R. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med. 2004 Dec 7;141(11):829-34.</citation>
    <PMID>15583223</PMID>
  </reference>
  <reference>
    <citation>Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003 Aug 6;42(3):466-72.</citation>
    <PMID>12906974</PMID>
  </reference>
  <reference>
    <citation>Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87. doi: 10.1016/j.jacc.2009.02.007.</citation>
    <PMID>19389557</PMID>
  </reference>
  <reference>
    <citation>Potet J, Rahmouni A, Mayer J, Vignaud A, Lim P, Luciani A, Dubois-Randé JL, Kobeiter H, Deux JF. Detection of myocardial edema with low-b-value diffusion-weighted echo-planar imaging sequence in patients with acute myocarditis. Radiology. 2013 Nov;269(2):362-9. doi: 10.1148/radiol.13121811. Epub 2013 May 21.</citation>
    <PMID>23696680</PMID>
  </reference>
  <reference>
    <citation>Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J. 2007 Jun;28(11):1326-33. Epub 2007 May 9.</citation>
    <PMID>17493945</PMID>
  </reference>
  <reference>
    <citation>Kindermann I, Kindermann M, Kandolf R, Klingel K, Bültmann B, Müller T, Lindinger A, Böhm M. Predictors of outcome in patients with suspected myocarditis. Circulation. 2008 Aug 5;118(6):639-48. doi: 10.1161/CIRCULATIONAHA.108.769489. Epub 2008 Jul 21. Erratum in: Circulation.2008 Sep 16;118(12): e493.</citation>
    <PMID>18645053</PMID>
  </reference>
  <reference>
    <citation>Grün S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O, Kispert EM, Hill S, Ong P, Klingel K, Kandolf R, Sechtem U, Mahrholdt H. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol. 2012 May 1;59(18):1604-15. doi: 10.1016/j.jacc.2012.01.007. Epub 2012 Feb 22.</citation>
    <PMID>22365425</PMID>
  </reference>
  <reference>
    <citation>Mahfoud F, Ukena C, Kandolf R, Kindermann M, Böhm M, Kindermann I. Blood pressure and heart rate predict outcome in patients acutely admitted with suspected myocarditis without previous heart failure. J Hypertens. 2012 Jun;30(6):1217-24. doi: 10.1097/HJH.0b013e328352b9ca.</citation>
    <PMID>22473019</PMID>
  </reference>
  <reference>
    <citation>Ukena C, Mahfoud F, Kindermann I, Kandolf R, Kindermann M, Böhm M. Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur J Heart Fail. 2011 Apr;13(4):398-405. doi: 10.1093/eurjhf/hfq229. Epub 2011 Jan 14.</citation>
    <PMID>21239404</PMID>
  </reference>
  <reference>
    <citation>Magnani JW, Danik HJ, Dec GW Jr, DiSalvo TG. Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J. 2006 Feb;151(2):463-70.</citation>
    <PMID>16442915</PMID>
  </reference>
  <reference>
    <citation>Mendes LA, Dec GW, Picard MH, Palacios IF, Newell J, Davidoff R. Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J. 1994 Aug;128(2):301-7.</citation>
    <PMID>8037097</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2016</study_first_submitted>
  <study_first_submitted_qc>March 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2016</study_first_posted>
  <last_update_submitted>November 21, 2017</last_update_submitted>
  <last_update_submitted_qc>November 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute myocarditis</keyword>
  <keyword>Dilated cardiomyopathy</keyword>
  <keyword>Magnetic resonance imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Myocarditis</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

